Methodological and ethical aspects of randomized controlled clinical trials in minors with malignant diseases (vol 57, pg 599, 2011)

被引：0

作者：

Rothenberger, Lillian G.

Henschel, Andreas Dirk

Schrey, Dominik

Becker, Andreas

Boos, Joachim

机构：

来源：

PEDIATRIC BLOOD & CANCER | 2012年 / 59卷 / 01期

关键词：

D O I：

10.1002/pbc.24164

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：205 / 205

页数：1

共 50 条

[41] Comorbid anxiety disorders and baseline medication regimens predict clinical outcomes in individuals with co-occurring bipolar disorder and alcohol dependence: Results of a randomized controlled trial. (vol 188, pg 361, 2011)
Prisciandaro, J. J.
Brown, D. G.
Brady, K. T.
Tolliver, B. K.
PSYCHIATRY RESEARCH, 2021, 295
[42] Early Versus Delayed Percutaneous Coronary Intervention for Patients With Non-ST Segment Elevation Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Clinical Trials (vol 81, pg 223, 2013)
Rajpurohit, Naveen
Garg, Nadish
Garg, Rajeev
Choudhary, Abhishek
Fresen, John
Boren, Sue
Dellsperger, Kevin C.
Webel, Richard
Aggarwal, Kul
Alpert, Martin A.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2013, 81 (07) : 1255 - 1255
[43] RETRACTION: The safety profile of probiotic VSL#3®. A meta-analysis of safety data from double-blind, randomized, placebo-controlled clinical trials (Retraction of Vol 24, Pg 963, 2020)
Panetta, V.
Bacchieri, A.
Papetti, S.
De Stefani, E.
Navarra, P.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (21) : 6443 - 6443
[44] Lack of beneficial effects of granulocyte colony-stimulating factor in patients with subacute myocardial infarction undergoing late revascularization: a double-blind, randomized, placebo-controlled clinical trial (vol 66, pg 219, 2011)
Karimabad, H. M.
Shabestari, M.
Baharvand, H.
ACTA CARDIOLOGICA, 2015, 70 (04) : 500 - 500
[45] RETRACTED: Efficacy of oral bisphosphonates for preventing hip fracture in disabled patients with neurological diseases: a meta-analysis of randomized controlled trials among the Japanese population (Retracted article. See vol. 33, pg. 1181, 2017)
Iwamoto, Jun
Takeda, Tsuyoshi
Matsumoto, Hideo
CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (06) : 1141 - 1148
[46] Stroke Unit Care in a Real-Life Setting: Can Results From Randomized Controlled Trials Be Translated Into Every-Day Clinical Practice? An Observational Study of Hospital Data in a Large Australian Population (vol 40, pg 10, 2009)
Gattellari
STROKE, 2009, 40 (04) : E286 - E286
[47] RETRACTED: Efficacy of Menatetrenone (Vitamin K2) against Non-Vertebral and Hip Fractures in Patients with Neurological Diseases Meta-Analysis of Three Randomized, Controlled Trials (Retracted article. See vol. 38, pg. 479, 2018)
Iwamoto, Jun
Matsumoto, Hideo
Takeda, Tsuyoshi
CLINICAL DRUG INVESTIGATION, 2009, 29 (07) : 471 - 479
[48] Twelve-month follow-up of Six Week Extended Dose Navirapine randomized controlled trials: differential impact of extended-dose nevirapine on mother-to-child transmission and infant death by maternal CD4 cell count (vol 25, pg 767, 2011)
Omer, S. B.
AIDS, 2012, 26 (18) : 2427 - 2428
[49] An Allopurinol-Controlled, Multicenter, Randomized, Open-Label, Parallel Between-Group, Comparative Study of Febuxostat (TMX-67), a Non-Purine-Selective Inhibitor of Xanthine Oxidase, in Patients With Hyperuricemia Including Those With Gout in Japan: Phase 2 Exploratory Clinical Study (vol 17, pg S44, 2011)
Kamatani, Naoyuki
Fujimori, Shin
Hada, Toshikazu
Hosoya, Tatsuo
Kohri, Kenjiro
Nakamura, Toshitaka
Ueda, Takanori
Yamamoto, Tetsuya
Yamanaka, Hisashi
Matsuzawa, Yuji
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2014, 20 (06) : E3 - E3
[50] Phase III randomized, placebo-controlled study of cetuximab plus brivanib alaninate versus cetuximab plus placebo in patients with metastatic, chemotherapy-refractory, wild-type K-RAS colorectal carcinoma: The NCIC Clinical Trials Group and AGITG CO.20 Trial (vol 31, pg 2477, 2013)
Siu, L. L.
Shapiro, J. D.
Jonker, D. J.
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (18) : 2124 - 2124

← 1 2 3 4 5 →